Cargando…
Methylene Blue Blocks and Reverses the Inhibitory Effect of Tau on PMCA Function
Methylene blue (MB) is a synthetic phenothiazine dye that, in the last years, has generated much debate about whether it could be a useful therapeutic drug for tau-related pathologies, such as Alzheimer’s disease (AD). However, the molecular mechanism of action is far from clear. Recently we reporte...
Autores principales: | Berrocal, Maria, Caballero-Bermejo, Montaña, Gutierrez-Merino, Carlos, Mata, Ana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678728/ https://www.ncbi.nlm.nih.gov/pubmed/31323781 http://dx.doi.org/10.3390/ijms20143521 |
Ejemplares similares
-
Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity
por: Berrocal, Maria, et al.
Publicado: (2021) -
Methylene blue accelerates liquid-to-gel transition of tau condensates impacting tau function and pathology
por: Huang, Yongqi, et al.
Publicado: (2023) -
Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
por: Hosokawa, Masato, et al.
Publicado: (2012) -
Comparative Study of Toluidine Blue O and Methylene
Blue Binding to Lysozyme and
Their Inhibitory Effects on Protein Aggregation
por: Saha, Baishakhi, et al.
Publicado: (2018) -
Methylene Blue: Revisited
por: Ginimuge, Prashant R., et al.
Publicado: (2010)